Log In
BCIQ
Print this Print this
 

DLX105 topical

  Manage Alerts
Collapse Summary General Information
Company Cell Medica Ltd.
DescriptionTopical formulation of an anti-tumor necrosis factor (TNF) alpha mAb fragment
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/12/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today